McGuireWoods Consulting today announced that Gena McGroarty was promoted to vice president of MWCAdvocacy effective January 1.
McGuireWoods Consulting announced today it has opened a Tallahassee office with the arrival of veteran lobbyists Sean Stafford, Rhett O’Doski and Ryder Rudd.
McGuireWoods Romania celebrated its 10th anniversary in Bucharest with a client reception on December 5, 2017.
McGuireWoods Consulting President L.F. Payne and Executive Vice President and Chairman-elect Mark Bowles were recently tapped to serve on Virginia Governor-elect Ralph Northam’s Transition Committee. Mark has also been named a co-chair of the Inaugural Committee.
McGuireWoods’ Board of Partners has elected Jonathan P. Harmon to succeed Richard Cullen as McGuireWoods’ chairman. In addition, the board appointed J. Tracy Walker IV to follow Thomas E. Cabaniss as the firm’s managing partner.
The legislature adjourned following a grueling short session on Friday, June 29, 2018. The joint adjournment resolution includes an option to bring legislators back into session Tuesday, November 27, 2018 after the election. All 170 Senate and House seats across the state are contested on November 6. The Democrats seek to shift the power of the legislature, hoping to break the Republican supermajority in November. Once the legislature is back in session there are no restrictions on what legislation can be considered during the post-election session.
Your weekly North Carolina political news report.
Number of the Week: 120
The number of days until the 2018 midterm elections. The latest polling data from RealClearPolitics has Democrats leading Republicans by 7.4 percentage points in a generic congressional ballot.
This Week: Pandemic bill marked up, Senate committees hold hearings on drug costs and Medicaid fraud, CMS says yes to Oklahoma but no to Massachusetts.
GA-18-380: This report examines the progress the progress the Veterans Health Administration (VHA) has made improving opioid safety through its Opioid Safety Initiative (OSI).
An overview of the upcoming week in Congress from the McGuireWoods Consulting Tax Policy Update Team.
This month, President Trump announced his plan to lower drug prices. The plan does not call for a major overhaul of drug companies’ pricing practices, but does include some proposals that they oppose. Much of Trump’s plan is in the form of suggested actions, and it will take time for actual detailed proposals to be put forward.